- Home
- GNRC vs PEN Comparison
GNRC vs PEN Comparison
Compare GNRC & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GNRC | PEN |
|---|---|---|
| Founded | 1959 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.1B | 12.6B |
| IPO Year | 2009 | 2015 |
Fundamental Metrics
Financial Performance| Metric | GNRC | PEN |
|---|---|---|
| Price | $184.83 | $323.57 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 17 | 16 |
| Target Price | $211.75 | ★ $360.14 |
| AVG Volume (30 Days) | ★ 1.0M | 244.2K |
| Earning Date | 04-29-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1155.56 |
| EPS | ★ 3.64 | 1.70 |
| Revenue | ★ $4,209,147,000.00 | $1,403,665,000.00 |
| Revenue This Year | $17.36 | $14.34 |
| Revenue Next Year | $12.51 | $13.71 |
| P/E Ratio | ★ $50.50 | $189.22 |
| Revenue Growth | N/A | ★ 17.50 |
| 52 Week Low | $134.80 | $221.26 |
| 52 Week High | $296.44 | $362.41 |
Technical Indicators
Market Signals| Indicator | GNRC | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 32.11 | 51.41 |
| Support Level | $135.53 | $315.31 |
| Resistance Level | $225.67 | $329.14 |
| Average True Range (ATR) | 8.02 | 2.07 |
| MACD | -1.80 | -0.60 |
| Stochastic Oscillator | 4.32 | 35.52 |
Price Performance
Historical ComparisonAbout GNRC Generac Holdlings Inc.
Generac designs and manufactures power generation equipment serving residential, commercial, and industrial markets. It offers standby generators, portable generators, lighting, outdoor power equipment, and a suite of clean energy products. Sales generated in the United States account for the majority of total sales.
About PEN Penumbra Inc.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.